Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Rebecca Wilkes's Articles

ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform

BERLIN, Germany, and OXFORD, United Kingdom, May 15, 2019 / B3C newswire / -- ProBioGen AG, a premier German service & technology provider for complex biologics and Vaccitech, Ltd., a spin-out company from the University of Oxford’s Jenner Institute, one of the most renowned vaccine research centers in the world, today jointly announced signing a license agreement.

Boyds bolsters Regulatory Affairs team with senior appointment

In support of its continuing growth plans, Boyds, the leading consultancy business that supports the development of pharmaceutical and biotech products for patient benefit, has appointed a new CMC regulatory affairs professional.

Boyds reports record-breaking growth 12-months on from Queen’s Award

Boyds, the leading consultancy business that supports the development of pharmaceutical and biotech products for patient benefit, has reported record-breaking growth in its overseas turnover in the 12-months since it was recognised with one of the UK’s most prestigious awards, The Queen’s Awards for Enterprise.

Catsci: Cardiff-based company expanding after Welsh Government support

A Cardiff-based company specialising in helping pharmaceutical companies bring new therapeutics to market is set to create 16 highly skilled new jobs thanks to Welsh Government support.

Immunocore to Present New Tebentafusp (IMCgp100) Data in Advanced Melanoma at Upcoming 2019 ASCO Annual Meeting

(Oxfordshire, UK and Conshohocken, Pennsylvania and Rockville, Maryland, US, 16 May 2019) Immunocore Limited, a leading T cell receptor (TCR) biotechnology company, will present new mechanism of action data in advanced uveal and cutaneous melanoma from the tebentafusp clinical research programme at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on 3 June 2019.

RSSL introduces cell based bioassays to enhance biologics service offering

Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical and healthcare sectors, has introduced a cell based bioassay service to meet rising demand for potency assessments.

AMSBIO: Low Adhesion Plates Facilitate Retinal Organoid Culture

AMSBIO reports on how several leading European research groups have used their Lipidure® coated microplates to help culture physiologically functional, light-responsive retinal organoids.

 

Horton International: Entrust Resource Solutions acquire second company 

To support their ambitious growth plans, Dundee-based resourcing group Entrust Resource Solutions have acquired a second company, SCI Search and Selection, increasing their portfolio to three consultancies. 

First Patient Dosing in Phase 1 Clinical Trial of Ultra-rapid Acting Insulin Product Candidtae AT247 for Diabetes

Cambridge, UK., 7th May 2019: Arecor Limited (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces dosing of the first patient in its Phase I clinical trial for its ultra-rapid acting insulin product candidate, AT247. 

Absolute Antibody Launches Mouse Bispecific Antibody Reagents

Oxford, UK, May 7, 2019. Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the launch of the first commercially available mouse knob-into-hole (KIH) bispecific antibody reagents.

Pages: Previous1234567...12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.